Biologics Facility Design & Pharmaceutical Regulatory Aspects

  • Check with publisher
  • Published date: February 21, 2017
    • Fremont, California, United States

Overview:
This course explores some of the best practices of pharmaceutical facility design with an emphasis on regulatory aspects. FDA and other global regulatory body requirements are discussed and the reasoning behind them.

Why should you Attend:
The attendee will learn what is important in facility design from the FDA and regulatory standpoint. The attendee will understand what FDA looks for during a facility inspection. The attendee will be able to minimize possible design errors which are difficult and expensive to fix post-build. The attendee will understand what FDA looks for in reviewing the facility design and the flow patterns.

Areas Covered in the Session:
Best design practices for Pharma facilities
Best design practices for biologics facilities
Regulatory compliance for Pharma and biologics facilities design
Flow patterns and cross contamination controls

Who Will Benefit:
Compliance Manager
Facility Manager
Validation Manager
Regulatory Manager
Design Team/Architects

Speaker Profile:
John R. Godshalk currently works for the Biologics Consulting Group as a Senior Consultant. John served as a Senior Review Biochemical Engineer and Lead cGMP inspector in the Division of Manufacturing and Product Quality at CBER, FDA. He contributed to formulation of FDA policy.

Contact Detail:
Compliance4All DBA NetZealous,
Phone: +1-800-447-9407
Email: support@compliance4All.com

Result 0 votes
Compliance4All
0 votes

Useful information

  • Avoid scams by acting locally or paying with PayPal
  • Never pay with Western Union, Moneygram or other anonymous payment services
  • Don't buy or sell outside of your country. Don't accept cashier cheques from outside your country
  • This site is never involved in any transaction, and does not handle payments, shipping, guarantee transactions, provide escrow services, or offer "buyer protection" or "seller certification"

Related listings

  • US, EU and Japan GMP Requirements

    US, EU and Japan GMP Requirements

    Pharmacology - Drug Development Minnesota (Minneapolis) September 5, 2018 Check with publisher

    Course "US, EU and Japan GMP Requirements: Practical ICH Area Differences, Healthcare Authority Inspection Focus " has been pre-approved by RAPS as eligible for up to 12 credits towards a participant's RAC recertification upon full completion. Descri...

  • Validation and 21 CFR Part 11 Compliance of Computer Systems

    Validation and 21 CFR Part 11 Compliance of Computer Systems

    Pharmacology - Drug Development Philadelphia (Pennsylvania) September 5, 2018 Check with publisher

    Course "Validation and 21 CFR Part 11 Compliance of Computer Systems" has been pre-approved by RAPS as eligible for up to 12 credits towards a participant's RAC recertification upon full completion. Description: The Problem We have all heard of Compu...

  • FDA Scrutiny of Promotion and Advertising Practices

    FDA Scrutiny of Promotion and Advertising Practices

    Pharmacology - Drug Development San Francisco (California) September 5, 2018 Check with publisher

    Course "FDA Scrutiny of Promotion and Advertising Practices" has been pre-approved by RAPS as eligible for up to 12 credits towards a participant's RAC recertification upon full completion. Description: If you go "off label" with advertising and prom...